Humana Medicare Advantage policy covers AngioDynamics NanoKnife IRE
AngioDynamics says Humana’s Medicare Advantage coverage policy supports broader access to NanoKnife IRE for prostate and liver cancer.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
AngioDynamics Announces Humana Medicare Advantage Coverage Policy Supporting Broader Access to NanoKnife® IRE for Prostate and Liver Cancer
For best results when printing this announcement, please click on link below: AngioDynamics Announces Humana Medicare Advantage Coverage Policy Supporting Broader Access to NanoKnife(®) IRE for Prostate and Liver Cancer Policy Applies Medical Necessity Criteria Across Medicare Administrative Contractor (MAC) Jurisdicti